UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000032257 |
|---|---|
| Receipt number | R000030084 |
| Scientific Title | Phase I/II study of bi-weekly docetaxel and cisplatin plus S-1 (bi-weekly DCS) as first-line therapy for advanced esophageal cancer. |
| Date of disclosure of the study information | 2018/04/16 |
| Last modified on | 2023/10/20 09:20:23 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2018/04/16 01:57:30 | ||
| 2 | Update | 2019/02/19 01:12:24 | Key inclusion criteria Key exclusion criteria |
|
| 3 | Update | 2019/04/20 14:38:27 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Email1 Organization Organization Address Address Tel |
|
| 4 | Update | 2022/11/13 16:46:08 | Date of IRB Last follow-up date |
|
| 5 | Update | 2023/10/20 09:20:23 | Recruitment status |
